Potential utility of pretreatment serum miRNAs for optimal treatment selection in advanced high-grade serous ovarian cancer.

Takashi UeharaJuntaro MatsuzakiHiroshi YoshidaYuto OgawaJunichiro MiuraHitoshi FujimiyaYusuke YamamotoJunpei KawauchiSatoko TakizawaKan YonemoriHiromi SakamotoKen KatoMitsuya IshikawaTakahiro Ochiya

Published in: Japanese journal of clinical oncology (2024)

Pretreatment microRNA profiles could be used to select subgroups of patients who benefited more from primary debulking surgery or neoadjuvant chemotherapy and might contribute to selecting the optimal primary treatment modality in advanced high-grade serous ovarian cancer patients.

Keyphrases

high grade
neoadjuvant chemotherapy
low grade
locally advanced
minimally invasive
squamous cell carcinoma
radiation therapy
acute coronary syndrome
risk assessment
early stage
coronary artery disease
replacement therapy
human health
atrial fibrillation
percutaneous coronary intervention
smoking cessation